Enrico V.
- Country
- Italy
- Department
- Medical Oncology Unit 2
Research Overview
Data & Insights
Has run more than one trial at 0 of 26 partner sites.
Specializations
Pancreatic Cancer Research
This investigator specializes in the treatment of pancreatic ductal adenocarcinoma (PDAC), conducting advanced clinical research to improve therapeutic outcomes for patients with stage I-III disease.
- Pre-operative Chemotherapy Optimization
- Treatment Duration Assessment
- Advanced Chemotherapy Regimens
The investigator focuses on evaluating the effectiveness of various chemotherapy protocols, including mFOLFIRINOX and PAXG regimens in pancreatic cancer treatment.
Therapeutic Strategy Development
The investigator's work centers on developing optimal treatment strategies through comparative analysis of different chemotherapy approaches for resectable pancreatic cancer.
- Treatment Duration Optimization
- Surgical Timing Strategies
- Patient Outcome Assessment
A key focus lies in determining the most effective duration of pre-operative treatment to enhance patient outcomes.
Clinical Outcomes Research
The investigator evaluates event-free survival (EFS) in pancreatic cancer patients, comparing different therapeutic approaches to establish optimal treatment protocols.
- Survival Analysis
- Treatment Response Assessment
- Clinical Efficacy Evaluation
Research efforts concentrate on identifying factors that influence treatment success in pancreatic cancer therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.